Identification of a novel candidate splice site mutation (0874+1G>A) in a type 3 von Willebrand disease patient

• References

• 1 Keeney S, Cumming AM. The molecular biology of von Willebrand disease. Clin Lab Haematol 2001; 23: 209-230.
• 2 Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994; 71: 520-525.
• 3 Mazurier C, Ribba AS, Gaucher C. et al. Molecular genetics of von Willebrand disease. Ann Genet 1998; 4: 34-43.
• 4 James PD, Notley C, Hegadorn C. et al. The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study. Blood 2007; 109: 145-154.
• 5 Gallinaro L, Sartorello F, Pontara E. et al. Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease. Thromb Haemost 2006; 96: 711-716.
• 6 Goodeve A, Eikenboom J, Castaman G. et a. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007; 109: 112-121.
• 7 James PD, Notley C, Hegadorn C. et al., for the Association of Hemophilia Clinic Directors of Canada.. The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study. Blood 2007; 109: 145-154.
• 8 Mancuso DJ, Tuley EA, Westfield LA. et al. Structure of the human gene for von Willebrand Factor. J Biol Chem 1989; 264: 19514-19527.
• 9 Mazurier C, Meyer D. Molecular basis of von Willebrand disease. Baillieres Clin Haematol 1996; 9: 229-241.
• 10 Michiels JJ, Gadisseur A, Budde U. et al. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences. Semin Thromb Hemost 2005; 31: 577-601.
• 11 Eikenboom JC. Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology. Best Pract Res Clin Haematol 2001; 14: 365-379.
• 12 Schneppenheim R, Brassard J, Krey S. et al. Defective dimerisation of von Willebrand factor subunits due to a Cys-Arg mutation in type IID von Willebrand disease. Proc Natl Acad Sci USA 1996; 93: 3581-3586.
• 13 Goodeve AC, Eikenboom JC, Ginsburg D. et al. ISTH SSC Subcommittee on von Willebrand factor.. A standard nomenclature for von Willebrand factor gene mutations and polymorphisms. On behalf of the ISTH SSC Subcommittee on von Willebrand factor. Thromb Haemost 2001; 85: 929-931.
• 14 Antonarakis SE. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 1998; 11: 1-3.
• 15 Sadler JE, Budde U, Eikenboom JC. et al. The Working Party On Von Willebrand Disease Classification.. Update on the pathophysiology and classification of von Willebrand disease: are port of the Subcommitteeon von Willebrand Factor. J Thromb Haemost 2006; 4: 2103-2114.
• 16 Cumming A, Grundy P, Keeney S. et al.; the UK Haemophilia Centre Doctors‘ Organisation.. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease. Thromb Haemost 2006; 96: 630-641.